WST West Pharmaceutical Services, Inc. logo

WST West Pharmaceutical Services, Inc.

Healthcare
$316.42+0.09%ClosedMarket Cap: $22.35B

As of 2026-05-25

Valuation

View Details

P/E (TTM)

37.83

PEG

186.41

P/B

7.62

P/S

6.94

EV/EBITDA

27.72

DCF Value

$93.35

FCF Yield

2.0%

Div Yield

0.3%

Margins & Returns

Gross Margin

36.2%

Operating Margin

20.7%

Net Margin

16.9%

ROE

17.9%

ROA

13.2%

ROIC

15.2%

Financials

View All
PeriodRevenueNet IncomeEPS
Q1 null$844.9M$138.8M$
Q4 null$805.0M$132.1M$
FY null$3.07B$493.7M$
Q3 null$804.3M$140.0M$

Analyst Ratings

View All

Consensus

Buy

Target (Consensus)

$315.83

Target (Median)

$315.00

Target Range

$295.00 - $340.00

2 Strong Buy10 Buy3 Hold0 Sell0 Strong Sell
BarclaysEqual Weight
2026-04-27
BarclaysEqual Weight
2026-02-13
Evercore ISI GroupOutperform
2026-02-03
BarclaysEqual Weight
2025-10-27
UBSBuy
2025-10-24

Trading Activity

Insider Trades

View All
Campbell Shane Aldenofficer: SVP, Proprietary Segment
SellThu May 14
Campbell Shane Aldenofficer: SVP, Proprietary Segment
SellThu May 14
Campbell Shane Aldenofficer: SVP, Proprietary Segment
SellThu May 14
Campbell Shane Aldenofficer: SVP, Proprietary Segment
SellThu May 14
Pucci Paolodirector
SellWed May 06

Company Info

Sector

Healthcare

Industry

Medical - Instruments & Supplies

Country

US

Exchange

Beta

1.17

West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging components. It also provides drug containment solutions, including Crystal Zenith, a cyclic olefin polymer in the form of vials, syringes, and cartridges; and self-injection devices, as well as a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. It serves pharmaceutical, diagnostic, and medical device companies. The company distributes its products through its sales force and distribution network, as well as contract sales agents and regional distributors. West Pharmaceutical Services, Inc. was incorporated in 1923 and is headquartered in Exton, Pennsylvania.

Peers